{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:39:33Z","timestamp":1789799973220,"version":"4.0.1"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,4,15]]},"DOI":"10.2169\/internalmedicine.7741-21","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T22:13:07Z","timestamp":1633385587000},"page":"1299-1304","source":"Crossref","is-referenced-by-count":14,"title":["Complete Response Induced by Concurrent Chemoradiotherapy in a Patient with NUT Carcinoma"],"prefix":"10.2169","volume":"61","author":[{"given":"Joji","family":"Muramatsu","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohichi","family":"Takada","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Sugita","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Department of Radiology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Takagi","sequence":"additional","affiliation":[{"name":"Proton Therapy Center, Sapporo Teishinkai Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Murase","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Ameda","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Arihara","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Miyanishi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh-Ichi","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Radiology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mao N, Liao Z, Wu J, et al. Diagnosis of NUT carcinoma of lung origin by next-generation sequencing: case report and review of the literature. Cancer Biol Ther 20: 150-156, 2019.","DOI":"10.1080\/15384047.2018.1523852"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Haack H, Johnson LA, Fly CJ, et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol 33: 984-991, 2009.","DOI":"10.1097\/PAS.0b013e318198d666"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Franchi A. Pathology of Sinonasal Tumors and Tumor-Like Lesions. 1st ed. Springer, Germany, 2019: 110-113.","DOI":"10.1007\/978-3-030-29848-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ayee R, Ofori MEO, Wright E, Quaye O. Epstein Barr virus associated lymphomas and epithelia cancers in humans. J Cancer 17: 1737-1750, 2020.","DOI":"10.7150\/jca.37282"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Wooff JC, Weinreb I, Perez-Ordonez B, Magee JF, Bullock MJ. Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract. Am J Surg Pathol 35: 1786-1793, 2011.","DOI":"10.1097\/PAS.0b013e3182363b78"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Shanfeld RL, Edelman J, Willis JE, et al. Immunohistochemical analysis of neural markers in peripheral primitive neuroectodermal tumors (pPNET) without light microscopic evidence of neural differentiation. Appl Immunohistochem Mol Morphol 5: 78-86, 1997.","DOI":"10.1097\/00022744-199706000-00002"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Chin M, Yokoyama R, Sumi M, et al. Multimodal treatment including standard chemotherapy with vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for the Ewing sarcoma family of tumors in Japan: results of the Japan Ewing sarcoma study 04. Pediatr Blood Cancer 67: e28194, 2020.","DOI":"10.1002\/pbc.28194"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Chau NG, Ma C, Danga K, et al. An anatomical site and genetic-based prognostic model for patients with nuclear protein in testis (NUT) midline carcinoma: analysis of 124 patients. JNCI Cancer Spectr 4: pkz094, 2019.","DOI":"10.1093\/jncics\/pkz094"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Chau NG, Hurwitz S, Mitchell CM, et al. Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck. Cancer 122: 3632-3640, 2016.","DOI":"10.1002\/cncr.30242"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Mertens F, Wiebe T, Adlercreutz C, Mandahl N, French CA. Successful treatment of a child with t(15;19) - positive tumor. Pediatr Blood Cancer 49: 1015-1017, 2007.","DOI":"10.1002\/pbc.20755"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Storck S, Kennedy AL, Marcus KJ, et al. Pediatric NUT-midline carcinoma: therapeutic success employing a sarcoma based multimodal approach. Pediatr Hematol Oncol 34: 231-237, 2017.","DOI":"10.1080\/08880018.2017.1363839"},{"key":"12","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1186\/s12885-018-5087-x","volume":"18","author":"K Arimizu","year":"2018","unstructured":"12. Arimizu K, Hirano G, Makiyama C, Matsuo M, Sasaguri T, Makiyama A. NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing's sarcoma family of tumors: a case report. BMC Cancer 18: 1134, 2018.","journal-title":"BMC Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Leeman R, Pinkney K, Bradley JA, et al. NUT carcinoma without upfront surgical resection: a case report. J Pediatr Hematol Oncol 43: e707-e710, 2021.","DOI":"10.1097\/MPH.0000000000001865"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sopfe J, Greffe B, Treece AL. Metastatic NUT midline carcinoma treated with aggressive neoadjuvant chemotherapy, radiation, and resection: a case report and review of the literature. J Pediatr Hematol Oncol 43: e73-e75, 2021.","DOI":"10.1097\/MPH.0000000000001860"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Womer RB, West DC, Krailo MD, et al. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the children's oncology group. J Clin Oncol 30: 4148-4154, 2012.","DOI":"10.1200\/JCO.2011.41.5703"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Prasad M, Baheti A, Ramadwar M, Chinnaswamy G, Vora T, Qureshi S. Pediatric NUT carcinoma is a rare and challenging tumor: single center experience of five children. Oncologist 24: e1232-e1235, 2019.","DOI":"10.1634\/theoncologist.2019-0358"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Shapiro GI, LoRusso P, Dowlati A, et al. A phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma. Br J Cancer 124: 744-753, 2020.","DOI":"10.1038\/s41416-020-01180-1"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lewin J, Soria JC, Stathis A, et al. Phase Ib trial with birabresib, a small-molecule inhibitor of bromodomain and extraterminal proteins, in patients with selected advanced solid tumors. J Clin Oncol 36: 3007-3014, 2018.","DOI":"10.1200\/JCO.2018.78.2292"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. French CA, Kutok JL, Faquin WC, et al. Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol 15: 4135-4139, 2004.","DOI":"10.1200\/JCO.2004.02.107"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/8\/61_7741-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T03:31:01Z","timestamp":1650079861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/8\/61_7741-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,15]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7741-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,15]]},"article-number":"7741-21"}}